Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial

Summary

Trial Summary
Subjects with multiple myeloma (MM) who are considered eligible for high-dose therapy and autologous stem cell transplantation by the transplant team at WCI will be enrolled in the study.

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:

Example: Are you newly diagnosed? What treatments have you already been on?

Contacts: